Ads
related to: pepto bismol for loose stools- Food and Diet Tips
Get Diet Tips and Recipes to Manage
Your Symptoms.
- Check Your Symptoms
Take A 5-Question Quiz To Learn
More About Your IBS-C Symptoms
- IBS-C/CIC Tips & Support
Sign Up To Receive Treatment
and IBS-C/CIC Management Tips.
- Free Digital Cookbook
Prepare Tasty Gut-Friendly Meals
With A Free Digital Cookbook.
- Food and Diet Tips
wiserlifestyles.com has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
Pepto-Bismol was first sold in 1900 [20] by a doctor in New York. It was originally sold as a remedy for infant diarrhea by Norwich Pharmacal Company under the name "Bismosal: Mixture Cholera Infantum". [20] It was renamed Pepto-Bismol in 1919. Norwich Eaton Pharmaceuticals was acquired by Procter and Gamble in 1982. [21]
Antimotility agents are drugs used to alleviate the symptoms of diarrhea. These include loperamide (Imodium), bismuth subsalicylate (Pepto-Bismol), [1] diphenoxylate with atropine (Lomotil), and opiates such as paregoric, tincture of opium, codeine, and morphine.
Iron supplements may cause a grayish-black stool that should be distinguished from melena, [3] as should black coloration caused by a number of medications, such as bismuth subsalicylate (the active ingredient in Pepto-Bismol), or by foods such as beetroot, black liquorice, or blueberries. [4]
Steatorrhea refers to bulky, foul-smelling, oily stool that tends to be pale in color and float in the toilet bowl, resisting flushing. ... But it also typically leads to greasy, loose stools, and ...
Some research has found that prebiotics can improve stool consistency and the number of bowel movements, as well as reduce bloating among adults struggling with constipation.
The active ingredient in Kaopectate has changed since its original creation. Originally, kaolinite was used as the adsorbent and pectin as the emollient. Attapulgite (a type of absorbent clay) replaced the kaolinite in the 1980s, but was banned by the U.S. Food and Drug Administration in a ruling made in April 2003.